Details for Patent: 8,653,058

Which drugs does patent 8,653,058 protect, and when does it expire?

Patent 8,653,058 protects KYBELLA and is included in one NDA.

Summary for Patent: 8,653,058

Title:	Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
Abstract:	The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.
Inventor(s):	Hodge; Robert Emil (Thousand Oaks, CA), Webster; Jeffrey Douglas (Thousand Oaks, CA), Moriarty; Robert M. (Michiana Shores, IN)
Assignee:	Kythera Biopharmaceuticals, Inc. (Calabasas, CA)
Application Number:	13/207,337
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,653,058
Patent Claim Types: see list of patent claims	Composition; Formulation;

Drugs Protected by US Patent 8,653,058

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	KYBELLA	deoxycholic acid	SOLUTION;SUBCUTANEOUS	206333-001	Apr 29, 2015	AP	RX	Yes	Yes			Y